[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myomo Inc (MYO)

Myomo Inc (MYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 49,458
  • Shares Outstanding, K 38,639
  • Annual Sales, $ 40,930 K
  • Annual Income, $ -15,570 K
  • EBIT $ -14 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.47
  • Price/Sales 1.34
  • Price/Cash Flow N/A
  • Price/Book 6.09

Options Overview Details

View History
  • Implied Volatility 293.54% (+106.27%)
  • Historical Volatility 133.45%
  • IV Percentile 53%
  • IV Rank 18.81%
  • IV High 1,273.78% on 09/18/25
  • IV Low 66.41% on 06/27/25
  • Expected Move (DTE 28) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 15
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 3,319
  • Open Int (30-Day) 3,075
  • Expected Range 1.2800 to 1.2800

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.09
  • Number of Estimates 2
  • High Estimate $-0.08
  • Low Estimate $-0.11
  • Prior Year $-0.11
  • Growth Rate Est. (year over year) +18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8400 +52.38%
on 05/19/26
1.5900 -19.50%
on 06/11/26
+0.4410 (+52.56%)
since 05/18/26
3-Month
0.6050 +111.57%
on 03/31/26
1.5900 -19.50%
on 06/11/26
+0.5551 (+76.58%)
since 03/18/26
52-Week
0.6050 +111.57%
on 03/31/26
2.6800 -52.24%
on 06/20/25
-1.4300 (-52.77%)
since 06/18/25

Most Recent Stories

More News
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026

RALEIGH, NC / ACCESS Newswire / June 18, 2026 / iAccess Alpha today announced that it will host its Virtual Best Ideas Summer Investment Conference on June 23-24, 2026, bringing together small and micro-cap...

ECOR : 8.43 (-3.11%)
BOSC : 4.36 (+0.93%)
MYO : 1.2800 (-9.86%)
AMROF : 0.2350 (+11.90%)
ROC : 4.51 (-4.45%)
EXYN : 6.84 (+7.89%)
ACCS : 5.80 (-6.45%)
SKYX : 1.0800 (+4.85%)
NNBR : 2.79 (+0.36%)
TII : 2.16 (-0.92%)
TI.TO : 3.04 (unch)
MIND : 5.27 (+4.98%)
Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 1.2800 (-9.86%)
Myomo Announces Participation in Upcoming Investor Conferences

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 1.2800 (-9.86%)
Myomo Appoints Joseph M. Manko to its Board of Directors

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 1.2800 (-9.86%)
Myomo Reports First Quarter 2026 Financial and Operating Results

Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year ...

MYO : 1.2800 (-9.86%)
Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.

Myomo, Inc. (NYSE American: MYO) , a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace , announces expanded access to the MyoPro...

MYO : 1.2800 (-9.86%)
Myomo to Report First Quarter 2026 Financial Results on May 7

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...

MYO : 1.2800 (-9.86%)
Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement

Myomo, Inc. (NYSE American: MYO) , a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of...

MYO : 1.2800 (-9.86%)
Myomo Appoints William J Febbo to its Board of Directors

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb...

MYO : 1.2800 (-9.86%)
OPRX : 4.98 (-1.97%)
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Fourth quarter revenue of $11.4 million, full year revenue of $40.9 million 42% of fourth quarter revenue from recurring patient sources ...

MYO : 1.2800 (-9.86%)

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

3rd Resistance Point 1.6528
2nd Resistance Point 1.5663
1st Resistance Point 1.4231
Last Price 1.2800
1st Support Level 1.1934
2nd Support Level 1.1069
3rd Support Level 0.9637

See More

52-Week High 2.6800
Fibonacci 61.8% 1.8873
Fibonacci 50% 1.6425
Fibonacci 38.2% 1.3977
Last Price 1.2800
52-Week Low 0.6050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.